GLRX participates in the redox process of various cells by regulating protein S-sulfonylation and is closely related to the occurrence and development of various diseases, such as cardiovascular disease [58, 59], acute lung injury [60], ischemia/reperfusion injury [61], and nonalcoholic fatty liver (NAFL) [62]. Here, GLRX is linked to cardiovascular disorder.